PL1853296T3 - Zastosowanie cyklicznego undekapeptydu do wytwarzania leku do podawania w trakcie zdarzeń niedokrwienia mięśnia sercowego - Google Patents
Zastosowanie cyklicznego undekapeptydu do wytwarzania leku do podawania w trakcie zdarzeń niedokrwienia mięśnia sercowegoInfo
- Publication number
- PL1853296T3 PL1853296T3 PL06704161T PL06704161T PL1853296T3 PL 1853296 T3 PL1853296 T3 PL 1853296T3 PL 06704161 T PL06704161 T PL 06704161T PL 06704161 T PL06704161 T PL 06704161T PL 1853296 T3 PL1853296 T3 PL 1853296T3
- Authority
- PL
- Poland
- Prior art keywords
- medicament
- preparation
- administration during
- during myocardial
- cyclic undecapeptide
- Prior art date
Links
- 125000004122 cyclic group Chemical group 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000000302 ischemic effect Effects 0.000 title 1
- 230000002107 myocardial effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05000357 | 2005-01-10 | ||
| PCT/EP2006/050140 WO2006072639A1 (fr) | 2005-01-10 | 2006-01-10 | Utilisation d’un undecapeptide cyclique pour la preparation d’un médicament administrable lors de situations ischemiques myocardiques |
| EP06704161A EP1853296B1 (fr) | 2005-01-10 | 2006-01-10 | Utilisation d'un undécapeptide cyclique pour la préparation d'un médicament administrable lors de situations ischémiques myocardiaques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1853296T3 true PL1853296T3 (pl) | 2012-12-31 |
Family
ID=34933239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06704161T PL1853296T3 (pl) | 2005-01-10 | 2006-01-10 | Zastosowanie cyklicznego undekapeptydu do wytwarzania leku do podawania w trakcie zdarzeń niedokrwienia mięśnia sercowego |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8889629B2 (https=) |
| EP (1) | EP1853296B1 (https=) |
| JP (1) | JP2008526816A (https=) |
| DK (1) | DK1853296T5 (https=) |
| ES (1) | ES2387682T3 (https=) |
| PL (1) | PL1853296T3 (https=) |
| PT (1) | PT1853296E (https=) |
| SI (1) | SI1853296T1 (https=) |
| WO (1) | WO2006072639A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2023948A1 (en) * | 2006-05-04 | 2009-02-18 | Michel Ovize | Use of cyclosporin a or melle4-cyclosporin for the treatment of acute myocardial infarction |
| WO2009098533A1 (en) * | 2008-02-08 | 2009-08-13 | Debiopharm Sa | Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy |
| WO2011141891A1 (en) | 2010-05-12 | 2011-11-17 | Debio Recherche Pharmaceutique S.A. | Use of cycloundecadepsipeptide compounds |
| GB201217560D0 (en) | 2012-10-02 | 2012-11-14 | Mitopharm Ltd | Novel cyclic depsipeptide compounds and their uses |
| EP2967567B1 (en) * | 2013-03-15 | 2022-08-24 | Boston Scientific Scimed, Inc. | System for controlling a tissue-stapling operation with pressurized fluid |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999019471A1 (en) * | 1997-10-16 | 1999-04-22 | Board Of Regents, The University Of Texas System | Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| PT1056729E (pt) * | 1998-02-27 | 2005-04-29 | Pfizer Prod Inc | Derivados de n-[ciclo di- ou tri-aza di-insaturado de cinco membros substituido) carbonil] guanidina para o tratamento de isquemia |
| PT1091975E (pt) * | 1998-07-01 | 2006-05-31 | Debiopharm Sa | Nova ciclosporina com um perfil de actividade melhorado |
| US6790935B1 (en) * | 1999-02-05 | 2004-09-14 | Debiopharm S.A. | Cyclosporin derivatives and method for the production of said derivatives |
-
2006
- 2006-01-10 PT PT06704161T patent/PT1853296E/pt unknown
- 2006-01-10 JP JP2007549909A patent/JP2008526816A/ja active Pending
- 2006-01-10 US US11/794,245 patent/US8889629B2/en not_active Expired - Fee Related
- 2006-01-10 WO PCT/EP2006/050140 patent/WO2006072639A1/fr not_active Ceased
- 2006-01-10 SI SI200631402T patent/SI1853296T1/sl unknown
- 2006-01-10 DK DK06704161.6T patent/DK1853296T5/da active
- 2006-01-10 ES ES06704161T patent/ES2387682T3/es not_active Expired - Lifetime
- 2006-01-10 EP EP06704161A patent/EP1853296B1/fr not_active Expired - Lifetime
- 2006-01-10 PL PL06704161T patent/PL1853296T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1853296A1 (fr) | 2007-11-14 |
| ES2387682T3 (es) | 2012-09-28 |
| EP1853296B1 (fr) | 2012-06-20 |
| US8889629B2 (en) | 2014-11-18 |
| DK1853296T5 (da) | 2013-03-18 |
| JP2008526816A (ja) | 2008-07-24 |
| SI1853296T1 (sl) | 2012-10-30 |
| WO2006072639A1 (fr) | 2006-07-13 |
| DK1853296T3 (da) | 2012-09-03 |
| PT1853296E (pt) | 2012-09-26 |
| US20090023640A1 (en) | 2009-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL187461A (en) | Use of a 1-dioxinogirimycin derivative for the preparation of a single therapy drug for the treatment of pomp disease | |
| IL181304A (en) | Use of dihydroprididone for the preparation of a drug for the treatment of spinal cord dysplasia | |
| EP1793803A4 (en) | SUSTAINED RELEASE MEDICINAL COMPOSITIONS WHICH CAN BE APPROPRIATELY IMPLANTED | |
| IL178302A (en) | Use of Natalizumab in the preparation of a drug to reduce the need for steroid therapy | |
| IL187387A0 (en) | Solid dosage formulations of narcotic drugs having improved buccal adsorption | |
| IL183357A0 (en) | Oral medicament for the modified release of at least one active principle, in multimicrocapsule form | |
| IL184424A0 (en) | Cxcr4 antagonists for the treatment of hiv infection | |
| IL183929A0 (en) | Use of inerferon - ?? in the preparation of a medicament | |
| IL181827A0 (en) | Donepezil salts suitable for the preparation of pharmaceutical compositions | |
| UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
| ZA200709788B (en) | Cannabinold active pharmaceutical ingredient for Improved dosage forms | |
| EP1757273A4 (en) | PREPARATION FOR ORAL ADMINISTRATION | |
| IL183930A0 (en) | Use of cladribine for preparation of pharmaceutical compositions | |
| TWI366457B (en) | Use of a beta2-adrenoceptor agonist for the preparation of a dermatological medicament | |
| EP1729786A4 (en) | ADMINISTRATION OF CISPLATIN BY INHALATION | |
| ZA200807348B (en) | Dosage aerosols for the administration of pharmaceutical preparations | |
| GB0524958D0 (en) | Transdermal administration of active agents | |
| GB0402492D0 (en) | Pharmaceutically active compounds | |
| PT2379066E (pt) | Uso de antagonistas opioides para a preparação de um medicamento no tratamento das doenças degenerativas da retina | |
| ZA200802745B (en) | Kit for parenteral administration of medicaments | |
| EP1757282A4 (en) | USE OF KAURANE COMPOUNDS IN THE MANUFACTURE OF MEDICAMENTS | |
| SI1853296T1 (sl) | Uporaba cikličnega undekapeptida za pripravo zdravila za dajanje med miokardnimi ishemičnimi dogodki | |
| EP1877004A4 (en) | COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF RAPAMYCIN ANALOGUES WITH MEDICAL DEVICES FOR LONG-TERM EFFECT | |
| ZA201004520B (en) | N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds,preparation thereof and therapeutic application thereof | |
| PL1858496T3 (pl) | Poprzezskórny układ terapeutyczny do aplikowania środków przeciwbólowych |